Renaissance Technologies
MRTX

Renaissance Technologies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Renaissance Technologies’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-240,927
Closed -$16.8M – 4509
2022
Q3 		$16.8M Sell
240,927
-27,373
-10% -$2.03M 0.02% 760
2022
Q2 		$18M Buy
268,300
+174,300
+185% +$11.1M 0.02% 783
2022
Q1 		$7.73M Buy
+94,000
New +$9.61M 0.01% 1297
2021
Q3 		– Sell
-41,907
Closed -$6.77M – 3950
2021
Q2 		$6.77M Sell
41,907
-47,993
-53% -$7.71M 0.01% 1442
2021
Q1 		$15.4M Sell
89,900
-94,200
-51% -$18.7M 0.02% 926
2020
Q4 		$40.4M Buy
+184,100
New +$39.8M 0.04% 427
2020
Q1 		– Sell
-62,100
Closed -$8M – 3909
2019
Q4 		$8M Sell
62,100
-293,800
-83% -$28.3M 0.01% 1586
2019
Q3 		$27.7M Sell
355,900
-93,100
-21% -$8.74M 0.02% 783
2019
Q2 		$46.2M Buy
449,000
+398,700
+793% +$31M 0.04% 526
2019
Q1 		$3.69M Buy
50,300
+11,400
+29% +$776K ﹤0.01% 1999
2018
Q4 		$1.65M Sell
38,900
-58,300
-60% -$2.32M ﹤0.01% 2336
2018
Q3 		$4.58M Buy
97,200
+92,600
+2,013% +$5.16M ﹤0.01% 1862
2018
Q2 		$227K Buy
+4,600
New +$174K ﹤0.01% 3046
2017
Q2 		– Sell
-164,302
Closed -$854K – 3408
2017
Q1 		$854K Buy
+164,302
New +$900K ﹤0.01% 2599
2016
Q4 		– Sell
-106,800
Closed -$706K – 3522
2016
Q3 		$706K Sell
106,800
-128,920
-55% -$686K ﹤0.01% 2705
2016
Q2 		$1.29M Buy
+235,720
New +$3.76M ﹤0.01% 2423
2015
Q2 		– Sell
-23,900
Closed -$701K – 3431
2015
Q1 		$701K Buy
+23,900
New +$561K ﹤0.01% 2470
2014
Q2 		– Sell
-21,000
Closed -$400K – 3030
2014
Q1 		$400K Buy
+21,000
New +$436K ﹤0.01% 2427

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Renaissance Technologies's MRTX Position: Q4 2022 in Review

Renaissance Technologies sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2022, closing a stake of 240,927 shares — an estimated $16.8M sold.

Renaissance Technologies first reported a position in MRTX in Q1 2014 and held it in 18 quarters. The position peaked at $46.2M in Q2 2019. 233 funds tracked by Wall St. Rank hold MRTX as of Q4 2022.

  • Renaissance Technologies reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Renaissance Technologies sold 240,927 Mirati Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $16.8M.
  • Renaissance Technologies first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2014 and held it in 18 quarters.
  • Renaissance Technologies's Mirati Therapeutics, Inc. Common Stock position peaked at $46.2M in Q2 2019.
  • 233 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.